AssayIndex
Reports by quarter

Reports submitted in 2026-Q1 · page 16

Rule AX-R12 added. Dataset v2 schema published. Median purity for the quarter is 99.22 % area, n=806. Read the 2026-Q1 state-of-the-index report →

806 records21 pagesmedian on this page 99.27 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043497GHRP-6QSTQST-2508-M5445Janoshik2026-Q198.425.8297.2Buyer-sourced0FAIL
AX-2026-043055RetatrutideKPKP-2511-K4818Medutest2026-Q196.753.47100.3Buyer-sourced0PASS
AX-2026-042967AdipotideMKMMKM-2511-F3656Kestrel2026-Q199.394.93—Buyer-sourced0PASS
AX-2026-042633TirzepatideSWBSWB-2601-V7010Janoshik2026-Q198.594.8290.2Buyer-sourced0PASS
AX-2026-042616ARA-290HJHJ-2508-C7084Nordanalyt2026-Q199.425.12—Buyer-sourced0PASS
AX-2026-042370SemaxHomopeptideHOMO-2601-D3090VendorInvestigate2026-Q199.117.29—Buyer-sourced1MARGINAL
AX-2026-042359SemaxHomopeptideHOMO-2602-S3200Medutest2026-Q199.669.30—Buyer-sourced0PASS
AX-2026-042304EpitalonTFCTFC-2508-W1380Medutest2026-Q199.036.97104.4Buyer-sourced1MARGINAL
AX-2026-042299EpitalonTFCTFC-2508-W1380Kestrel2026-Q198.846.70—Buyer-sourced1FAIL
AX-2026-042294SemaglutideTFCTFC-2508-A1033Janoshik2026-Q199.183.85106.7Buyer-sourced0PASS
AX-2026-042278SemaglutideTFCTFC-2602-H9925Janoshik2026-Q198.551.4595.9Buyer-sourced0PASS
AX-2026-041722TirzepatideTFSTFS-{CAT}-1353Janoshik2026-Q199.224.88—Buyer-sourced0PASS
AX-2026-041466AOD-9604QYBQYB-2508-E5277Janoshik2026-Q199.673.64—Buyer-sourced0PASS
AX-2026-041462AOD-9604QYBQYB-2508-E5277Nordanalyt2026-Q199.344.26100.0Buyer-sourced0PASS
AX-2026-041440Thymosin α1QYBQYB-2511-V5408VendorInvestigate2026-Q199.813.10101.9Buyer-sourced0PASS
AX-2026-043457GHRP-2BCHBCH-2508-M4472Janoshik2026-Q198.855.18—Buyer-sourced0FAIL
AX-2026-043069ExenatideKPKP-2511-W5891Janoshik2026-Q198.163.8595.4Buyer-sourced0PASS
AX-2026-042794RetatrutideGGPepsGGPE-2510-R1919VendorInvestigate2026-Q198.513.97100.5Buyer-sourced0PASS
AX-2026-042654CJC-1295 (no DAC)SWBSWB-2512-S8187Janoshik2026-Q199.223.73103.5Buyer-sourced0PASS
AX-2026-042445SemaglutideHomopeptideHOMO-2511-C4492Medutest2026-Q199.604.86103.3Buyer-sourced0PASS
AX-2026-042380LeuprolideHomopeptideHOMO-2508-N3727Janoshik2026-Q199.755.23—Buyer-sourced1MARGINAL
AX-2026-042379LeuprolideHomopeptideHOMO-2508-N3727VendorInvestigate2026-Q199.665.39105.9Buyer-sourced1MARGINAL
AX-2026-042199RetatrutideTFCTFC-2508-V8915Janoshik2026-Q198.154.1789.8Buyer-sourced1MARGINAL
AX-2026-042104SemaxJEEPJEEP-2602-C8195Janoshik2026-Q199.747.8498.8Supplier-supplied0PASS
AX-2026-042071TriptorelinHYBHYB-2512-B7307PeptideMeter2026-Q199.494.78106.6Buyer-sourced0PASS
AX-2026-041465AOD-9604QYBQYB-2508-E5277Medutest2026-Q199.754.04—Buyer-sourced1FAIL
AX-2026-041239RetatrutideWWBWWB-2510-H1662Janoshik2026-Q199.685.00103.4Buyer-sourced0PASS
AX-2026-043675CJC-1295 (no DAC)PPGPPG-2509-V8167VendorInvestigate2026-Q199.935.75105.6Laboratory-retained0PASS
AX-2026-043661TB-500PPGPPG-2512-D8068PeptideMeter2026-Q199.283.39—Buyer-sourced0PASS
AX-2026-043585SS-31 (Elamipretide)SIGSIG-2512-6369Janoshik2026-Q199.306.47—Buyer-sourced0PASS
AX-2026-043583SS-31 (Elamipretide)SIGSIG-2512-6369Nordanalyt2026-Q199.327.0589.9Buyer-sourced1MARGINAL
AX-2026-042820Melanotan IIGGPepsGGPE-2509-H1678Nordanalyt2026-Q199.225.4792.9Buyer-sourced0PASS
AX-2026-042680Humanin (HNG)ERPERP-2601-P8786Janoshik2026-Q199.063.7598.7Buyer-sourced1MARGINAL
AX-2026-042625CJC-1295 with DACSWBSWB-2510-N6994Medutest2026-Q198.352.24—Buyer-sourced0PASS
AX-2026-042454SemaglutideHomopeptideHOMO-2511-C4492Janoshik2026-Q199.254.83100.5Buyer-sourced0PASS
AX-2026-042332TirzepatideTFCTFC-2508-L2482Medutest2026-Q198.401.68100.1Buyer-sourced1FAIL
AX-2026-042296SemaglutideTFCTFC-2508-A1033Kestrel2026-Q199.934.03105.0Buyer-sourced0PASS
AX-2026-042092BPC-157HYBHYB-2512-P8025VendorInvestigate2026-Q199.934.21102.7Buyer-sourced1MARGINAL
AX-2026-041942SemaxSinoPepSNP-2601-U4736Janoshik2026-Q199.557.32—Buyer-sourced1MARGINAL
AX-2026-041848BPC-157GSPGSP-2508-H3518VendorInvestigate2026-Q198.591.9688.5Laboratory-retained1MARGINAL